NHS blood test to ‘revolutionise' cancer treatment
A revolutionary blood test that allows personalised cancer treatment is set to be rolled out on the NHS in a world first.
The technique, known as a liquid biopsy, will become the standard test for lung cancer and also be offered to thousands of women with breast disease.
Speaking to The Telegraph, Prof Peter Johnson, the national clinical director for cancer at NHS England described it as a 'golden key' to unlock personalised treatment'.
In a landmark shift, the rapid tests will be offered to 20,000 patients this year, and could soon expand to cover six types of cancer.
Experts said the tests, which detect tumour DNA in the blood, would allow for 'live monitoring' of both disease and treatment, meaning faster diagnoses and fewer side effects.
Patients who have had a CT scan showing signs of the disease will be offered the test without having to wait for tissue biopsies. It may also help patients avoid chemotherapy altogether.
The advances could also save the NHS money, with an independent economic review suggesting the rollout could save £11 million a year in lung cancer treatment costs.
Prof Johnson said the shift would bring a 'new era' of personalised medicine.
He told the Telegraph: 'For patients it means that a single blood test can now give us a window into how their cancer may respond to treatment. It means we can better understand the genetic make-up of their disease and use this DNA test like a 'golden key' to unlock personalised treatment, at much greater speed.'
Peter Kyle, the Science Secretary, whose mother died from lung cancer, said the announcement had 'profound significance'.
He said: 'Imagine a world where most cancers are identified before symptoms even appear – not through invasive procedures or radiation-heavy scans, but through a simple blood draw during a routine check-up.
'This isn't science fiction. It's the near horizon of medical technology, and the UK is helping to lead the way.'
Mr Kyle added: 'I often think about what such technology might have meant for my mum and our family. The anxiety it might have spared, the time it could have saved, the different trajectory her treatment might have taken.
'For the thousands of families facing the same devastating diagnosis, this technology can be a game-changer.'
Wes Streeting, the Health Secretary, added: 'This incredibly exciting new test could save countless lives, giving thousands of people peace of mind.'
The announcement will see the NHS become the first health service in the world to roll-out a 'blood test-first' approach to diagnosing lung cancer.
In total, 15,000 patients with suspected lung cancer will be offered the tests, as well as around 5,000 women with advanced breast cancer who are not responding to treatment.
They will be offered liquid biopsies to see if they might respond to drugs which can slow or halt the progress of disease.
Breast cancer is the most common cancer in England, with around 50,000 women diagnosed every year. Lung cancer remains the biggest killer, with 35,000 deaths annually.
Experts said the breakthrough will make a critical difference in cutting the time it takes to diagnose and treat disease.
The advances will also allow medics to narrowly focus treatment as specifically as possible, meaning it is 'kinder' on the body, sparing patients from some of the worst side effects.
The test, which detects tumour DNA fragments circulating in the blood, allows clinicians to rapidly identify genetic mutations driving cancer, and match patients with therapies tailored to a tumour's genetic profile.
Professor Johnson said: 'Liquid biopsies are leading us into a new era of personalised cancer care and it's fantastic that we are now able to expand the use of this revolutionary test on the NHS to help tailor treatment for thousands of patients across the country.'
He said the advances could allow medics to deliver 'more targeted and kinder care for patients' sparing some chemotherapy.
'We are already seeing the difference this test can make in lung and breast cancer – and we hope to roll it out for patients with other forms of cancer in the near future,' he said.
The senior oncologist added that the approach had still more potential, as it may be able to screen apparently healthy patients for signs of disease.
'It's exciting that this approach has the potential to help us 'scan' the body in a single blood test to see where and how cancer may be developing and target it with speed and precision to help save more lives,' he said.
The announcement comes on the eve of the world's largest cancer conference, the American Society of Clinical Oncology's Annual Meeting (ASCO), which is expected to reveal results from a host of trials examining the role of liquid biopsy and precision medicines.
Dr Julie Gralow, ASCO chief medical officer, said the method allowed medics to carry out 'live monitoring at a level that is actually much more specific and early than waiting for it to show up on scans'.
As well as being used to diagnose patients, it can help to guide treatment, and 'to understand how the tumour is getting around the treatment,' she said.
'This is a cool way of not having to stick needles into wherever the cancer is, but just drawing blood,' she said. 'The benefit of looking in the blood is it shows the most active part of the cancer.'
Results from pilot NHS schemes for lung cancer show the approach can fast-track patients to start treatment two weeks earlier and avoid repeated scans, delays and needless toxic therapies.
Dr Isaac Garcia-Murillas, from the Molecular Oncology Group at The Institute of Cancer Research, London, said the potential patient benefits and cost savings were 'incredible'.
The researcher, who has worked in the field for more than a decade, said that as well as saving patients from tumour biopsies, which can be painful, the test also meant you could detect cancerous cells which would be 'undetectable' on any other test.
He said: 'This allows you to detect micro metastases way earlier – potentially a year before you could see it. The whole idea is this tumour is too small to be picked up by imaging. These are cells that are undetectable on other tests.'
He said the rollout of liquid biopsy was now 'unstoppable' with other experts saying it would 'transform' cancer care.
A pilot scheme in 176 hospitals tested the method in patients with non-small cell lung cancer (NSCLC) – the most common lung cancer. All such patients with stage three and four disease will now be eligible for the tests, under the national rollout.
The NHS has just begun offering the tests to around 1,000 women with advanced breast cancer, and will expand this to test for four types of gene mutations – expanding access to targeted treatments.
The technology is also being evaluated for four other cancers including pancreatic and gallbladder disease, which are some of the hardest to treat.
Ultimately such tests could be offered to all over 40s as part of screening methods to spot disease long before symptoms appear.
Experts have said this would be the 'holy grail', with the NHS currently testing such methods in the largest trial in the world.
Professor Dame Sue Hill, chief scientific officer for England, said: 'This represents a real step-change in care for eligible lung and breast cancer patients on the NHS.'
NHS will be world's first health service to roll out 'blood test-first' approach for lung cancer
by Peter Kyle
I remember the day my mum was diagnosed with lung cancer. The brutal suddenness of it. The feeling that time had frozen, and the questions about the uncertain journey ahead.
I remember the horrible uncertainty of waiting for the results and treatment options – weeks that, for so many families, matter more than words can express.
That's why today's announcement holds such profound significance, both professionally as Science and Innovation Secretary, and deeply personally as someone who has lost a loved one to lung cancer.
The NHS is about to become the first health service in the world to roll out a revolutionary 'blood test-first' approach for diagnosing suspected lung cancer.
This liquid biopsy test can detect minute fragments of tumour DNA circulating in a patient's bloodstream – allowing doctors to identify specific genetic variations and begin targeted treatment up to two weeks faster than traditional methods.
For the 40,000 people diagnosed with lung cancer each year in England, this isn't just a medical advancement – it's transformative.
Many patients will be spared unnecessary invasive biopsies. Some will avoid chemotherapy altogether. And all will benefit from faster access to the right treatment.
The word 'revolutionary' is often overused in technology discussions, but in this case, it's entirely warranted.
Precision medicine
This simple blood test represents the vanguard of a technological shift in healthcare – one that brings together genomic science, data analytics and artificial intelligence to deliver precision medicine at unprecedented speed.
And it is just the latest example of our mission to put the latest technology in the hands of doctors and patients, making our NHS fit for the future through our Plan for Change.
Earlier this week, we announced the roll-out of cutting-edge radiography machines in every region, giving better and faster cancer treatment to thousands of patients.
And we've already helped tens of thousands of suspected cancer patients get a faster diagnosis, making life-saving interventions.
What truly excites me about today's announcement is that this is just the beginning.
The technology behind these liquid biopsies points toward a future where routine blood tests could screen for multiple cancers simultaneously, detecting disease at its earliest, most treatable stages.
Imagine a world where most cancers are identified before symptoms even appear – not through invasive procedures or radiation-heavy scans, but through a simple blood draw during a routine check-up.
UK is helping to lead the way
This isn't science fiction. It's the near horizon of medical technology, and the UK is helping to lead the way.
I often think about what such technology might have meant for my mum and our family. The anxiety it might have spared, the time it could have saved, the different trajectory her treatment might have taken.
For the thousands of families facing the same devastating diagnosis, this technology can be a game-changer.
This is why we pursue scientific and technological progress with such determination – because behind every statistic, every clinical trial, every pilot programme, there are real people whose lives hang in the balance.
For the thousands diagnosed with lung and breast cancer each year who have felt the disease's devastating impact, this technological advancement offers something beyond medical treatment. It offers hope.
And we will continue to deliver that as we bring our health service into the 21st century by making the best possible testing and treatments available to patients on the NHS.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
an hour ago
- Sky News
'Don't kill the ill' vs 'What a relief': Two terminally ill people on the assisted dying vote
Over the past year, Sky News has been following the journeys of two people who are terminally ill and on opposite sides of the assisted dying debate. Philip, a Christian pastor, views it as suicide and says supporters of the bill need more faith. Clare, a former counsellor, thinks it should be a personal choice, which for her could offer a good death. Philip died two days before Friday's historic vote, which saw MPs vote in favour of assisted dying. "Kill the bill, don't kill the ill," he told Sky News days before he died. Philip said better palliative care can make all the difference. "I still believe it's because of money. It would save millions and millions if they bump off people like me and Clare and others." Philip was resting in a bed in his living room when we spoke to him. Doctors had told him he had just days left. He was struggling to eat and experiencing hallucinations. "Just now, I went to kiss [my wife] Pauline and she's not there." He pointed to a corner of a biscuit he'd been eating over the last three days that's "not even as big as my thumb". "That's the maximum amount of food I can eat because I'm blocked with cancer." "Logically, I should be screaming and ranting and shouting. But I've been organising things like the funeral," he said, explaining that his belief in Jesus means he's at peace with death, however it comes. At times he cries and very often, he winces in pain. Asked what it would mean if the vote was passed, Philip said it would be "a terrible step downwards". Assisted dying would desensitise the British public to death, he explained. "I personally am totally against it, because you're missing out on what God's planned for you. "Because even now, he knows what's going to happen in me, he knows what's going to happen in the other people." He added: "You'll miss the support of people who love you. Because there are people who love you. If you just reach out to them." Philip died on Wednesday morning, two days before the bill's third reading and ascension to the House of Lords. Clare is sitting in her friend's garden in Cirencester, Gloucestershire, surrounded by nature and absorbing the news that the vote has passed. She tells Sky News: "Oh what a relief! Thank goodness. Thank you to all those people who were brave." Clare has breast cancer which has spread to her bones. Her doctors say her lungs have hardened, making it more difficult for her to breathe. "I'm breathless all the time especially if I'm talking. I can't walk very far without being breathless. Now my heart has to work very, very hard to keep my oxygen levels up." Clare has supported the Terminally Ill Adults (End of Life) Bill from its inception and calls it a "difficult subject". "People are very fearful," she says, before acknowledging that concerns remain for vulnerable people at risk of coercion. "Lots of people have been in controlling relationships, and I really understand how that works. "I've got daughters and I can understand situations where people are thinking, 'oh, I don't want to be a burden on somebody else' and all of that. But I think it's [worth] remembering that this is one choice out of many." Clare is aware it is unlikely the law will change before she dies. "It won't for [be there] me and it hasn't come in time for lots of people, has it?" she says. "All the people that have gone before that would've liked this choice to avoid suffering and indignity." Clare turns 60 this year and is marking her birthday with 60 memorable days. "I'm enjoying life," she says with a big smile. "I don't want to die, but we all have to go."
Sky News
2 hours ago
- Sky News
US warplanes transit through UK as Trump considers striking Iran
Flight tracking data shows extensive movement of US military aircraft towards the Middle East in recent days, including via the UK. Fifty-two US military planes were spotted flying over the eastern Mediterranean towards the Middle East between Monday and Thursday. That includes at least 25 that passed through Chania airport, on the Greek island of Crete - an eight-fold increase in the rate of arrivals compared to the first half of June. The movement of military equipment comes as the US considers whether to assist Israel in its conflict with Iran. Of the 52 planes spotted over the eastern Mediterranean, 32 are used for transporting troops or cargo, 18 are used for mid-air refuelling and two are reconnaissance planes. Forbes McKenzie, founder of McKenzie Intelligence, says that this indicates "the build-up of warfighting capability, which was not [in the region] before". Sky's data does not include fighter jets, which typically fly without publicly revealing their location. An air traffic control recording from Wednesday suggests that F-22 Raptors are among the planes being sent across the Atlantic, while 12 F-35 fighter jets were photographed travelling from the UK to the Middle East on Wednesday. Many US military planes are passing through UK A growing number of US Air Force planes have been passing through the UK in recent days. Analysis of flight tracking data at three key air bases in the UK shows 63 US military flights landing between 16 and 19 June - more than double the rate of arrivals earlier in June. On Thursday, Sky News filmed three US military C-17A Globemaster III transport aircraft and a C-130 Hercules military cargo plane arriving at Glasgow's Prestwick Airport. Flight tracking data shows that one of the planes arrived from an air base in Jordan, having earlier travelled there from Germany. What does Israel need from US? Israeli Prime Minister Benjamin Netanyahu said on 15 March that his country's aim is to remove "two existential threats - the nuclear threat and the ballistic missile threat". Israel says that Iran is attempting to develop a nuclear bomb, though Iran says its nuclear facilities are only for civilian energy purposes. A US intelligence assessment in March concluded that Iran is not building a nuclear weapon. President Trump dismissed the assessment on Tuesday, saying: "I think they were very close to having one." Forbes McKenzie says the Americans have a "very similar inventory of weapons systems" to the Israelis, "but of course, they also have the much-talked-about GBU-57". The GBU-57 is a 30,000lb bomb - the largest non-nuclear bomb in existence. Mr McKenzie explains that it is "specifically designed to destroy targets which are very deep underground". Experts say it is the only weapon with any chance of destroying Iran's main enrichment site, which is located underneath a mountain at Fordow. Air-to-air refuelling could allow Israel to carry larger bombs Among the dozens of US aircraft that Sky News tracked over the eastern Mediterranean in recent days, more than a third (18 planes) were designed for air-to-air refuelling. "These are crucial because Israel is the best part of a thousand miles away from Iran," says Sky News military analyst Sean Bell. "Most military fighter jets would struggle to do those 2,000-mile round trips and have enough combat fuel." The ability to refuel mid-flight would also allow Israeli planes to carry heavier munitions, including bunker-buster bombs necessary to destroy the tunnels and silos where Iran stores many of its missiles. Satellite imagery captured on 15 June shows the aftermath of Israeli strikes on a missile facility near the western city of Kermanshah, which destroyed at least 12 buildings at the site. At least four tunnel entrances were also damaged in the strikes, two of which can be seen in the image below. Writing for Jane's Defence Weekly, military analyst Jeremy Binnie says it looked like the tunnels were "targeted using guided munitions coming in at angles, not destroyed from above using penetrator bombs, raising the possibility that the damage can be cleared, enabling any [missile launchers] trapped inside to deploy". "This might reflect the limited payloads that Israeli aircraft can carry to Iran," he adds. Penetrator bombs, also known as bunker-busters, are much heavier than other types of munitions and as a result require more fuel to transport. Israel does not have the latest generation of refuelling aircraft, Mr Binnie says, meaning it is likely to struggle to deploy a significant number of penetrator bombs. Israel has struck most of Iran's western missile bases Even without direct US assistance, the Israeli air force has managed to inflict significant damage on Iran's missile launch capacity. Sky News has confirmed Israeli strikes on at least five of Iran's six known missile bases in the west of the country. On Monday, the IDF said that its strategy of targeting western launch sites had forced Iran to rely on its bases in the centre of the country, such as Isfahan - around 1,500km (930 miles) from Israel. Among Iran's most advanced weapons are three types of solid-fuelled rockets fitted with highly manoeuvrable warheads: Fattah-1, Kheibar Shekan and Haj Qassam. The use of solid fuel makes these missiles easy to transport and fast to launch, while their manoeuvrable warheads make them better at evading Israeli air defences. However, none of them are capable of striking Israel from such a distance. Iran is known to possess five types of missile capable of travelling more than 1,500km, but only one of these uses solid fuel - the Sijjil-1. On 18 June, Iran claimed to have used this missile against Israel for the first time. Iran's missiles have caused significant damage Iran's missile attacks have killed at least 24 people in Israel and wounded hundreds, according to the Israeli foreign ministry. The number of air raid alerts in Israel has topped 1,000 every day since the start of hostilities, reaching a peak of 3,024 on 15 June. Iran has managed to strike some government buildings, including one in the city of Haifa on Friday. And on 13 June, in Iran's most notable targeting success so far, an Iranian missile impacted on or near the headquarters of Israel's defence ministry in Tel Aviv. Most of the Iranian strikes verified by Sky News, however, have hit civilian targets. These include residential buildings, a school and a university. On Thursday, one missile hit the Soroka Medical Center in Beersheba, southern Israel's main hospital. More than 70 people were injured, according to Israel's health ministry. Iranian foreign minister Abbas Araghchi said that Iran had struck a nearby technology park containing an IDF cyber defence training centre, and that the "blast wave caused superficial damage to a small section" of the hospital. However, the technology park is in fact 1.2km away from where the missile struck. Photos of the hospital show evidence of a direct hit, with a large section of one building's roof completely destroyed. Iran successfully struck the technology park on Friday, though its missile fell in an open area, causing damage to a nearby residential building but no casualties. Israel has killed much of Iran's military leadership It's not clear exactly how many people Israel's strikes in Iran have killed, or how many are civilians. Estimates by human rights groups of the total number of fatalities exceed 600. What is clear is that among the military personnel killed are many key figures in the Iranian armed forces, including the military's chief of staff, deputy head of intelligence and deputy head of operations. Key figures in the powerful Revolutionary Guard have also been killed, including the militia's commander-in-chief, its aerospace force commander and its air defences commander. On Thursday, Israeli Prime Minister Benjamin Netanyahu said that US assistance was not necessary for Israel to win the war. "We will achieve all our objectives and hit all of their nuclear facilities," he said. "We have the capability to do that." 3:49 Forbes McKenzie says that while Israel has secured significant victories in the war so far, "they only have so much fuel, they only have so many munitions". "The Americans have an ability to keep up the pace of operations that the Israelis have started, and they're able to do it for an indefinite period of time." Additional reporting by data journalist Joely Santa Cruz and OSINT producers Freya Gibson, Lina-Sirine Zitout and Sam Doak.
Sky News
2 hours ago
- Sky News
Ex-classmates died after being treated at same mental health hospital - as concerns raised over more deaths
They were former classmates who both died after receiving care from the same mental health hospital three years apart. Warning: This article contains reference to suicide Multiple failings led to the death of 22-year-old Alice Figueiredo - who took her own life in July 2015 - and the NHS trust responsible for her care was charged with corporate manslaughter. Last week, following a months-long trial, the trust was found not guilty of that charge but was convicted of serious health and safety failings. Karis Braithwate, who had gone to school with Alice, also died in 2018, having been treated by the same NHS trust. Reports seen by Sky News detail a decade of deaths at North East London NHS Foundation Trust (NELFT), with coroners repeatedly raising concerns about the mental health services provided by the trust - in particular at Goodmayes Hospital in Ilford. Rushed assessments and neglect were often cited. One patient was marked as alive and well, even though he had taken his own life inside the hospital the previous day. Another patient told staff he was hearing voices telling him to kill himself, yet staff did not remove crucial items from his possession - items he would later use to take his own life. Karis, 24, was sent to Goodmayes Hospital after she tried to take her own life at a train station in October 2018. The next day, staff spent 27 minutes assessing her and a further two minutes confirming their conclusion. She was discharged from hospital in the afternoon. She then went to a nearby railway station and took her own life. Her death came less than an hour after she had left the hospital. Karis had been friends with Alice, her mother said. The pair had been classmates at the same school. Karis told her mother she was upset at being put on the same ward where Alice had taken her own life three years earlier. Her stepfather Mark Bambridge called Karis sweet and kind and said she often "struggled with life". He felt relief when she was taken to hospital, saying: "She was in a place where she would be taken care of." Karis's mother - who asked not to be named - said her daughter confided in her about the neglect she endured at the hospital. Karis told her mother that her carer would sleep when they were supposed to be watching over her and said she never felt safe. "She spoke of her belongings going missing, of being treated with indifference and disrespect, and of staff who showed little concern for her wellbeing," her mother said. Karis's mother said her daughter was failed by the hospital and the family was offered only a "hollow, superficial and indifferent 'apology' from the administration team of those who were meant to protect her". In the wake of the verdict in Alice's case, Karis's mother said: "I am holding Alice's family in my thoughts and praying they receive the justice they - and we - so clearly need and deserve." A spokesperson for NELFT called Karis's death a "profound tragedy" and said the trust had conducted an in-depth review of patient safety since 2018, "resulting in significant changes in the way we assess risk of suicide". "We train our staff to consider the trauma in a patient's history, rather than focusing solely on their current crisis," the spokesperson added. "This approach allows us to see the person behind the diagnosis, making it easier to identify warning signs and support safe recovery." The trust said it had also improved record-keeping and communication between emergency workers and mental health practitioners. The man marked as alive after he'd died Sky News looked at more than 20 prevention of future death reports, which are written by a coroner to draw attention to a matter in which they think action could be taken to prevent future deaths. Behind each report is a different person, but there are some strikingly similar themes - failure to carry out adequate risk assessments; issues sharing and recording information; neglect. One report said staff at Goodmayes Hospital "panicked and did not follow policy" in the wake of a man's death in 2021, instead writing that he was still alive when he had died the day before. Speaking in response at the time, the trust said it had written a "detailed action plan" to address concerns raised. Another report said one woman developed deep vein thrombosis after she was left to sit motionless in her room. She had not eaten or drunk anything in the two days before her death, and the trust was criticised for failing to record her food intake. Responding to the report at the time, the trust said it had implemented new policies to learn from her death. Issues stretched beyond Goodmayes Hospital and spanned the entire NHS trust. One man was not given any community support and overdosed after his access to medication was not limited. Another man, a father of three, was detained under the Mental Health Act but released from Goodmayes after just a few hours. The 39-year-old was found dead two weeks later after being reported missing by his family. At his inquest, a coroner raised concerns about the lack of a detailed assessment around him, with a junior doctor saying he was the only doctor available for 11 wards and 200 patients. 'Don't kill yourself on my shift' It has been 10 years since Alice took her own life inside the walls of Goodmayes Hospital. But current patients say the issues haven't gone away. Teresa Whitbread said her 18-year-old granddaughter Chantelle was a high suicide risk but she still managed to escape from the hospital "20 times". "I walked in one day and said, 'Where is Chantelle?', and no one could tell me," she told Sky News. On another occasion, Chantelle managed to get into the medical room and stabbed herself and a nurse with a needle. She said one nurse told her granddaughter: "Don't kill yourself on my shift. Wait until you go home and kill yourself." Teresa grew emotional as she talked about her granddaughter, once a vibrant young girl and avid boxer, whose treatment is now managed by community services. "It's made her worse," Teresa said of Chantelle's experience at Goodmayes Hospital. "There's no care, there's no care plan, there's no treatment." The NEFLT said it could not comment on specific cases but added that "patient safety is our absolute priority, and we work closely with our patients and their families to ensure we provide compassionate care tailored to their needs". Chantelle's family say she is a shell of her former self and have begged mental health services not send her back to Goodmayes. "Something has to change, and if it doesn't change, [the hospital] needs to be closed down," Teresa said. "Because people are not safe in there."
